WallStreetZenWallStreetZen

NASDAQ: BLFS
Biolife Solutions Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BLFS past revenue growth

How has BLFS's revenue growth performed historically?
Company
-11.43%
Industry
7.75%
Market
16.96%
BLFS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BLFS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BLFS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BLFS earnings and revenue history

Current Revenue
$143.3M
Current Earnings
-$66.4M
Current Profit Margin
-46.4%

BLFS Return on Equity

Current Company
-19.3%
Current Industry
11.1%
Current Market
188%
BLFS's Return on Equity (-19.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BLFS announces earnings.

BLFS Return on Assets

Current Company
-15.6%
Current Industry
7.2%
BLFS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BLFS Return on Capital Employed

Current Company
-17.39%
Current Industry
9.7%
BLFS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BLFS vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BLFS$143.27M-$51.75M-$66.43M+48.65%N/A
ATRI$169.33M$37.62M$19.41M+2.12%-9.83%
EMBC$1.12B$207.60M$55.30M-2.03%-63.46%
ZJYLN/AN/AN/AN/AN/A
ATRC$399.25M-$8.11M-$30.44M+14.64%N/A
View Top Medical Stocks

BLFS earnings dates

Next earnings date
May 8, 2024

Biolife Solutions Earnings & Revenue FAQ

What were BLFS's earnings last quarter?

On Invalid Date, Biolife Solutions (NASDAQ: BLFS) reported Q4 2023 earnings per share (EPS) of -$0.30, up 73.91% year over year. Total Biolife Solutions earnings for the quarter were -$13.38 million. In the same quarter last year, Biolife Solutions's earnings per share (EPS) was -$1.15.

If you're new to stock investing, here's how to buy Biolife Solutions stock.

What was BLFS's earnings growth in the past year?

As of Q2 2024, Biolife Solutions's earnings has grown year over year. Biolife Solutions's earnings in the past year totalled -$66.43 million.

What is BLFS's earnings date?

Biolife Solutions's earnings date is Invalid Date. Add BLFS to your watchlist to be reminded of BLFS's next earnings announcement.

What was BLFS's revenue last quarter?

On Invalid Date, Biolife Solutions (NASDAQ: BLFS) reported Q4 2023 revenue of $32.73 million up 26.04% year over year. In the same quarter last year, Biolife Solutions's revenue was $44.26 million.

What was BLFS's revenue growth in the past year?

As of Q2 2024, Biolife Solutions's revenue has grown -11.43% year over year. This is 19.18 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 7.75%. Biolife Solutions's revenue in the past year totalled $143.27 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.